Real benefit of a protective factor against dementia: Importance of controlling for death. Example of sport practice

PLoS One. 2017 Apr 17;12(4):e0174950. doi: 10.1371/journal.pone.0174950. eCollection 2017.

Abstract

Objectives: To analyse the impact of a risk factor on several epidemiological indicators of death and dementia; the example of sport practice is presented.

Methods: A population of 3670 non-demented subjects living at home and aged 65 and older from the PAQUID study were followed for 22 years. Sport practice was documented at baseline. Dementia (according to DSM-III-R criteria) and death were assessed at each visit. Analyses were performed with an Illness-Death model, providing results on the risks of dementia and death, probabilities and life expectancies.

Results: A total of 743 subjects (20.2%) participated in regular sport practice. During the follow-up, the proportion of death was lower in the elderly people practicing sport (EPPS), whereas the proportion of incident dementia cases was the same. The adjusted model showed a decreased risk of dementia (HR = 0.84 (0.72-1.00)) and of death for non-demented subjects (HR = 0.61 (0.51-0.71)) for EPPS but a similar risk of death with dementia in both sport groups. The probability of remaining alive without dementia was higher in EPPS, whereas the probability of dying was lower. The mean lifetime without dementia was 3 years higher for the EPPS, but the mean lifetime with dementia was the same.

Discussion: A preventive measure on a protective factor that is more effective for preventing death than dementia could lead to an increased lifetime without dementia; however, the number of demented cases may remain unchanged, even if the risk of developing dementia is reduced. This dynamic is important to forecast the need for health care and social services for the elderly.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cohort Studies
  • Death
  • Dementia / epidemiology
  • Dementia / mortality
  • Dementia / prevention & control*
  • Female
  • France / epidemiology
  • Humans
  • Incidence
  • Male
  • Prospective Studies
  • Protective Factors
  • Risk Factors
  • Sports*

Grants and funding

The PAQUID cohort was supported by IPSEN France, NOVARTIS Pharma France, and the CNSA (Caisse Nationale de Solidarité et d’Autonomie). The research presented in this manuscript is original. The contents of this article are solely the responsibility of the authors. IPSEN, NOVARTIS and the CNSA did not fund this specific study. The funders had no role in the collection, management, analysis, or interpretation of the data and had no role in the preparation, review or approval of the manuscript.